Click for best price
Skin Cancer Diagnostics Therapeutics Market Size, Share 2023
On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.
This report aims to provide a comprehensive presentation of the global market for Skin Cancer Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Diagnostics and Therapeutics. This report contains market size and forecasts of Skin Cancer Diagnostics and Therapeutics in global, including the following market information:
Global Skin Cancer Diagnostics and Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Skin Cancer Diagnostics and Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.
We surveyed the Skin Cancer Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Skin Cancer Diagnostics and Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Skin Cancer Diagnostics and Therapeutics Market Segment Percentages, by Type, 2022 (%)
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma
Global Skin Cancer Diagnostics and Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Skin Cancer Diagnostics and Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Cancer Research Center
Others
Global Skin Cancer Diagnostics and Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Skin Cancer Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Skin Cancer Diagnostics and Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Skin Cancer Diagnostics and Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi
Abbott
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Skin Cancer Diagnostics and Therapeutics, market overview.
Chapter 2: Global Skin Cancer Diagnostics and Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Skin Cancer Diagnostics and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Skin Cancer Diagnostics and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Skin Cancer Diagnostics and Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Skin Cancer Diagnostics and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Skin Cancer Diagnostics and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Skin Cancer Diagnostics and Therapeutics Overall Market Size
2.1 Global Skin Cancer Diagnostics and Therapeutics Market Size: 2022 VS 2029
2.2 Global Skin Cancer Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Skin Cancer Diagnostics and Therapeutics Players in Global Market
3.2 Top Global Skin Cancer Diagnostics and Therapeutics Companies Ranked by Revenue
3.3 Global Skin Cancer Diagnostics and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Skin Cancer Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Skin Cancer Diagnostics and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Skin Cancer Diagnostics and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Skin Cancer Diagnostics and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Skin Cancer Diagnostics and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Skin Cancer Diagnostics and Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Basal Cell Carcinoma
4.1.3 Squamous Cell Carcinoma
4.1.4 Melanoma
4.2 By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Skin Cancer Diagnostics and Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Cancer Research Center
5.1.5 Others
5.2 By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Skin Cancer Diagnostics and Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2029
6.3.2 US Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.3.3 Canada Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.3.4 Mexico Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2029
6.4.2 Germany Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4.3 France Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4.4 U.K. Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4.5 Italy Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4.6 Russia Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.4.8 Benelux Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2029
6.5.2 China Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.5.3 Japan Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.5.4 South Korea Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.5.6 India Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2029
6.6.2 Brazil Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.6.3 Argentina Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2029
6.7.2 Turkey Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.7.3 Israel Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
6.7.5 UAE Skin Cancer Diagnostics and Therapeutics Market Size, 2018-2029
7 Skin Cancer Diagnostics and Therapeutics Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.2.4 Merck Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.3.4 Novartis Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.4.4 Pfizer Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Qiagen
7.5.1 Qiagen Company Summary
7.5.2 Qiagen Business Overview
7.5.3 Qiagen Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.5.4 Qiagen Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Qiagen Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.6.4 Roche Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.7.4 Sanofi Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.8.4 Abbott Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.9.4 AstraZeneca Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.10.4 Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Bristol-Myers Squibb Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Skin Cancer Diagnostics and Therapeutics Major Product Offerings
7.11.4 Eli Lilly Skin Cancer Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Skin Cancer Diagnostics and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Skin Cancer Diagnostics and Therapeutics Market Drivers in Global Market
Table 3. Skin Cancer Diagnostics and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Skin Cancer Diagnostics and Therapeutics in Global Market
Table 5. Top Skin Cancer Diagnostics and Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Skin Cancer Diagnostics and Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Skin Cancer Diagnostics and Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Skin Cancer Diagnostics and Therapeutics Product Type
Table 9. List of Global Tier 1 Skin Cancer Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Skin Cancer Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Skin Cancer Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Skin Cancer Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Skin Cancer Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Skin Cancer Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 32. GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 36. Merck Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 40. Novartis Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 44. Pfizer Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Qiagen Company Summary
Table 47. Qiagen Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 48. Qiagen Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Qiagen Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 52. Roche Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 56. Sanofi Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 60. Abbott Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 64. AstraZeneca Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 68. Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Skin Cancer Diagnostics and Therapeutics Product Offerings
Table 72. Eli Lilly Skin Cancer Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Skin Cancer Diagnostics and Therapeutics Segment by Type in 2022
Figure 2. Skin Cancer Diagnostics and Therapeutics Segment by Application in 2022
Figure 3. Global Skin Cancer Diagnostics and Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Skin Cancer Diagnostics and Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Skin Cancer Diagnostics and Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Skin Cancer Diagnostics and Therapeutics Revenue in 2022
Figure 8. By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Skin Cancer Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Skin Cancer Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Qiagen Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AstraZeneca Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly Skin Cancer Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
